Navigation Links
ImmunoDOT Mono G Test

ProductsImmunoDOT Mono G Test
Company GenBio
Item ImmunoDOT Mono G Test
Features 
  • ImmunoDOT uses a proprietary assay system simultaneously detecting six analyte reactivities.
  • ImmunoDOT has the western blot method advantages while assuring superior lot to lot precision by using defined antigens.
  • Ideal for smaller laboratories wanting highest quality.
  • May also be used as a supplemental testing method in larger laboratories to verify results.
Description The Mono-G Test is a qualitative enzyme immunoassay (EIA) that detects IgG antibodies to Epstein-Barr virus capsid antigen (EBV-VCA), Epstein-Barr early nuclear antigen (EBV-EBNA), cytomegalovirus (CMV), and Toxoplasma. When used in conjunction with Mono-M Test it is an aid in the serodiagnosis of infectious (EBV) mononucleosis and presumptive serodiagnosis of CMV or Toxoplasma mononucleosis-like syndrome.
Info GenBio
Customer Service: (858) 592-9300
Web site: http://www.genbio.com

Related medicine products :

1. ImmunoDOT Autoimmunity Screening Panel 4
2. ImmunoDOT Autoimmunity Screening Panel 6
3. ImmunoDOT™ DNA/ENA Autoimmunity Screening Panel
4. ImmunoDOT Thyroid Autoimmunity Test
5. ImmunoDOT Borrelia DotBlot G Test
6. ImmunoDOT Borrelia DotBlot M Test
7. ImmunoDOT Borrelia (Lyme) Test (with Recombinant Protein)
8. ImmunoDOT TORCH Test
9. ImmunoDOT Mono M Test
... EpochXP Workstations provide comprehensive neurological monitoring ... care unit to accurately access your ... over 15 years experience, and a ... EpochXP neurological monitoring systems have a ...
... powerful, multi-modality system capable of performing EP (including ... and train of four testing tests simultaneously. The ... The base weighs only 4.25 lbs. A complete ... desktop PC-based system with a custom cart can ...
... neuromonitoring system especially designed for surgical monitoring ... 16 channels and is equipped with two ... channel can be independently configured as either ... channel. Endeavor amplifiers are based on the ...
... Katena Products, Inc. is the ... dedicated exclusively to ophthalmic surgical ... to over 7,000 customers in ... a global network of distributors, ...
Medicine Products:
(Date:12/7/2009)... Researchers at the University of Chicago have discovered a ... has obstructive sleep apnea (OSA) or habitual snoring by ... the possibility of developing a relatively simple urine test ... alleviate the need for costly and inconvenient sleep studies ... percent of whom actually have OSA," said lead author ...
(Date:12/6/2009)... become a mainstay of multiple myeloma treatment may ... of patients who have received stem cell transplants ... clinical trial results to be presented by ... Society of Hematology,s (ASH) annual meeting on Sunday, ... Center, Room 243-245, 5:45 pm CT). , ...
(Date:12/6/2009)... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today ... 2b 003-A1 study, known as the 003 trial, ... relapsed and refractory multiple myeloma patients. These data ... at the 51st annual meeting of the American ... in this trial is complete (n=269), and full ...
(Date:12/6/2009)... of the community, in cooperation with the Greater VA Healthcare System ... This year,s attendance is expected to soar to more than 5,000 ... ... (PRWEB) December 6, 2009 -- Volunteer organizations and members ... in West Los Angeles, will once again create a holiday party. ...
(Date:12/5/2009)... Africa, December 5 The first Football,for Hope ... Town opened its doors,today (5 December 2009). FIFA ... Premier Helen Zille, 2010 FIFA World Cup Organising ... Football Association,President Kirsten Nematandani and Executive Mayor of ...
Breaking Medicine News(10 mins):Health News:Urine test for pediatric obstructive sleep apnea possible 2Health News:Bortezomib shows promise in reducing GVHD and reconstituting immune system in some patients 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 3Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3
... 11 On the eve of a vote to,expand ... be concerned that spirituality is about to be squeezed ... Speaker Fabian Nunez, California assemblymen are,flocking to the capitol ... 1, a bill,intended to provide universal health care coverage ...
... TORONTO, Dec. 11 /PRNewswire/ - A popular class of ... A new Canadian study released by,the Institute for Clinical ... the risk of heart failure, heart attacks and death., ... ICES scientists looked at,the glitazone class of drugs including ...
... as many as one in five people over age ... the body, some degree of backward leakage occurs across ... (MR). When sufficiently severe, MR causes buildup of blood ... or "shortness of breath"), a serious condition called congestive ...
... Several extraordinary recent achievements place the field of ... the Dec. 10 issue of Optics Express, papers ... nanojets" for biomedical applications and the longest photon ... date. According to Dr. Vasily Astratov from ...
... (Dec. 10, 2007) -- With findings highlighted on a ... Medical College in New York City have shed important ... Epithelial cells line the outside of nearly all organs. ... in developed epithelial cells that selects from a large ...
... Cold Spring Harbor Laboratory (CSHL) scientists recently led ... space radiation on astronauts. The results of their study ... the safety of crew members participating in long distance ... caused by space radiation will be important during extended ...
Other Medicine News:Health News:More evidence suggests diabetes drug may be dangerous 2Health News:More evidence suggests diabetes drug may be dangerous 3Health News:Exercise testing may help predict seriousness of mitral regurgitation 2Health News:IBM reports milestone in silicon nanophotonics 2Health News:Protein-dependent 'switch' regulates intracellular trafficking in epithelial cells 2Health News:Protein-dependent 'switch' regulates intracellular trafficking in epithelial cells 3Health News:Brain stem cells sensitive to space radiation 2Health News:Brain stem cells sensitive to space radiation 3
(Date:12/4/2009)... Suneva Medical, a privately-held aesthetic medical device company, ... President and Chief Financial Officer. In this role, ... administrative functions including finance, accounting, IT, IR, administration and ... Company,s senior management team. ,, "One of my ...
(Date:12/4/2009)... Shore and E. David Crawford presented results for prostate-specific ... end points of biochemical recurrence rate in a Phase ... or monthly leuprolide in prostate cancer patients during the ... received FIRMAGON 240/80 mg/month had a recurrence rate of ...
(Date:12/3/2009)... a subsidiary of Hill-Rom Holdings, Inc. (NYSE: ... Allen Amatech(TM) OEM (Original Equipment Manufacturer) business website ... the Allen Amatech(TM) brand identity and includes an online ... and design specifications for the products. "We hope to ...
Breaking Medicine Technology:Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Angelica Corporation Raises Bar Again for Increased Patient Safety 48022 1Angelica Corporation Raises Bar Again for Increased Patient Safety 48022 2Univisions Doctora Aliza Launches VidaySalud com 28TM 29 48017 1Univisions Doctora Aliza Launches VidaySalud com 28TM 29 48017 2Ortho Biotech Oncology Research 26 Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer 48014 1Ortho Biotech Oncology Research 26 Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer 48014 2Ortho Biotech Oncology Research 26 Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer 48014 3Ortho Biotech Oncology Research 26 Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer 48014 4